The role of discrimination in the relation between COVID-19 sequelae, psychological distress, and work impairment in COVID-19 survivors.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : Nature Publishing Group, copyright 2011-
    • Subject Terms:
    • Abstract:
      Perceived discrimination and work impairment are commonly observed in COVID-19 survivors, but their relationship has not been well understood. We aimed to evaluate the role of discrimination in the development of psychological distress and work impairment in COVID-19 survivors. From April 2020 to November 2021, 309 patients were recruited at two designated COVID-19 hospitals in Japan. Participants completed a standardized questionnaire including COVID-19 sequelae, psychological distress, impairments in work performance and perceived discrimination. The majority of participants (62.5%) experienced one or more COVID-19 sequelae. Psychological distress was observed in 36.9% and work impairment in 37.9%. In multivariate logistic regression analyses, COVID-19 sequelae and discrimination were associated with both psychological distress and work impairment. Mediation analysis demonstrated that the direct effect of sequelae on work impairment was non-significant after accounting for psychological distress, suggesting that the effect of sequelae on work impairment was mainly mediated through psychological distress. These findings were replicated in a subgroup analysis limited to patients with mild COVID-19. We conclude that discrimination plays an important role in the development of psychological distress and work impairment, and that both discrimination and psychological distress should be targets of intervention in COVID-19 survivors.
      (© 2022. The Author(s).)
    • References:
      Front Psychol. 2020 Aug 11;11:1821. (PMID: 32849073)
      Cognit Ther Res. 2020;44(6):1043-1051. (PMID: 32904454)
      Sleep Med. 2022 Mar;91:273-281. (PMID: 34802891)
      Psychol Methods. 2010 Dec;15(4):309-34. (PMID: 20954780)
      Biology (Basel). 2022 Jan 02;11(1):. (PMID: 35053059)
      Psychiatry Res. 2020 Oct;292:113297. (PMID: 32707218)
      Int J Methods Psychiatr Res. 2008;17(3):152-8. (PMID: 18763695)
      Arch Gen Psychiatry. 2003 Feb;60(2):184-9. (PMID: 12578436)
      Occup Med (Lond). 2020 Apr 20;70(2):95-100. (PMID: 32009152)
      Psychiatry Res. 2022 Jan;307:114337. (PMID: 34922241)
      Int J Environ Res Public Health. 2022 Jan 14;19(2):. (PMID: 35055744)
      Open Forum Infect Dis. 2021 Dec 21;9(2):ofab640. (PMID: 35106317)
      Eur J Psychotraumatol. 2022 Jan 28;13(1):2019980. (PMID: 35111284)
      Sci Rep. 2022 Feb 14;12(1):2419. (PMID: 35165301)
      Lancet Psychiatry. 2022 Oct;9(10):815-827. (PMID: 35987197)
      Am J Health Promot. 2021 Nov;35(8):1095-1104. (PMID: 34074154)
      Sci Rep. 2022 Apr 11;12(1):6039. (PMID: 35411017)
      J Neurol Sci. 2022 Mar 15;434:120162. (PMID: 35121209)
      Soc Sci Med. 2008 Aug;67(3):358-67. (PMID: 18524444)
      Nat Commun. 2022 Apr 12;13(1):1957. (PMID: 35413949)
      Front Sociol. 2020 Nov 30;5:588936. (PMID: 33869517)
      Lancet Infect Dis. 2020 Jul;20(7):782. (PMID: 32592670)
      Lancet Reg Health Am. 2022 Mar;7:100178. (PMID: 35018358)
      J Health Soc Behav. 2021 Dec;62(4):562-581. (PMID: 34605700)
      BMC Public Health. 2021 Aug 18;21(1):1563. (PMID: 34407792)
      BMC Res Notes. 2021 Sep 17;14(1):362. (PMID: 34535190)
      Brain Behav Immun. 2022 Mar;101:93-135. (PMID: 34973396)
      Cognit Ther Res. 2022;46(3):457-469. (PMID: 34803195)
      BMC Infect Dis. 2022 Jan 27;22(1):93. (PMID: 35086489)
      Infect Dis (Lond). 2021 Oct;53(10):737-754. (PMID: 34024217)
      J Transcult Nurs. 2020 Jul;31(4):326-332. (PMID: 32316872)
      JAMA. 2021 May 18;325(19):2015-2016. (PMID: 33825846)
      Int J Equity Health. 2021 Aug 28;20(1):192. (PMID: 34454508)
      Front Public Health. 2021 Jan 12;8:577018. (PMID: 33585379)
      Ann Epidemiol. 2021 Jul;59:5-9. (PMID: 33845112)
      Clin Infect Dis. 2021 Aug 2;73(3):e826-e829. (PMID: 33624010)
      J Occup Health. 2015;57(6):521-31. (PMID: 26345178)
      Sci Rep. 2022 Aug 25;12(1):14505. (PMID: 36008436)
      J Occup Health. 2018 Mar 27;60(2):156-162. (PMID: 29311438)
      Int J Soc Psychiatry. 2021 Sep;67(6):728-736. (PMID: 33161822)
    • Publication Date:
      Date Created: 20221223 Date Completed: 20221227 Latest Revision: 20230309
    • Publication Date:
      20230309
    • Accession Number:
      PMC9782263
    • Accession Number:
      10.1038/s41598-022-26332-6
    • Accession Number:
      36564428